Article Details

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Retrieved on: 2021-04-14 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity. View article details on hiswai:

Excerpt

... normalized to cells without virus (100%) or without plasma (0%). Data plotted as mean ± SEM for n = 5 convalescent human samples (human conv.) ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo